Guardant Health is engaging in strategic partnerships enabling global leaders in precision medicine
Increasing global access to Guardant Health’s liquid biopsy platforms for greater patient identification for targeted therapy and clinical trials.
Know-how: Bringing together Guardant Health’s innovation with the expertise, know how and service delivery of the partner
Quality: state-of-the-art technology platform and infrastructure supporting the delivery of a uniform, high standard of care across all hospital settings.
Contact Guardant Health
Volumes: A high throughput liquid biopsy testing facility established offering ctDNA NGS testing across the country.